Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation.

gastrointestinal microbiome liver transplant metabolic syndrome nonalcoholic fatty liver disease obesity management visceral obesity

Journal

Immunity, inflammation and disease
ISSN: 2050-4527
Titre abrégé: Immun Inflamm Dis
Pays: England
ID NLM: 101635460

Informations de publication

Date de publication:
01 2022
Historique:
revised: 26 08 2021
received: 02 07 2021
accepted: 14 09 2021
pubmed: 2 10 2021
medline: 5 4 2022
entrez: 1 10 2021
Statut: ppublish

Résumé

The obesity pandemic has resulted in an increasing demand for liver transplantation and has significantly altered the profile of liver transplant candidates in addition to affecting posttransplantation outcomes. In this review, we discuss a broad range of clinical approaches that warrant attention to provide comprehensive and patient-centred medical care to liver transplant recipients, and to be prepared to confront the rapidly changing clinical challenges and ensuing dilemmas. Adipose tissue is a complex and metabolically active organ. Visceral fat deposition is a key predictor of overall obesity-related morbidity and mortality. Limited pharmacological options are available for the treatment of obesity in the liver transplant population. Bariatric surgery may be an alternative in eligible patients. The rapidly increasing prevalence of nonalcoholic fatty liver disease (NAFLD) is a global concern; NAFLD affects both pre- and posttransplantation outcomes. Numerous studies have investigated pharmacological and nonpharmacological management of NAFLD and some of these have shown promising results. Liver transplant recipients are constantly exposed to numerous factors that result in intestinal microbiota alterations, which were linked to the development of obesity, diabetes type 2, metabolic syndrome (MS), NAFLD, and hepatocellular cancer. Microbiota modifications with probiotics and prebiotics bring gratifying results in the management of metabolic complications. Fecal microbiota transplantation (FMT) is successfully performed in many medical indications. However, the safety and efficacy profiles of FMT in immunocompromised patients remain unclear. Obesity together with immunosuppressive treatment, may affect the pharmacokinetic and/or pharmacodynamic properties of coadministered medications. Individualized immunosuppressive regimens are recommended following liver transplantation to address possible metabolic concerns. Effective and comprehensive management of metabolic complications is shown to yield multiple beneficial results in the liver transplant population and may bring gratifying results in improving long-term survival rates.

Identifiants

pubmed: 34598315
doi: 10.1002/iid3.538
pmc: PMC8669703
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-21

Informations de copyright

© 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.

Références

J Hypertens. 1998 Dec;16(12 Pt 2):2013-7
pubmed: 9886891
HPB (Oxford). 2015 Aug;17(8):713-22
pubmed: 26172138
World J Hepatol. 2015 Jun 8;7(10):1355-68
pubmed: 26052381
Dig Dis Sci. 2015 Apr;60(4):1036-44
pubmed: 25596720
Transpl Int. 2006 Dec;19(12):1000-5
pubmed: 17081230
Nutrients. 2019 Nov 19;11(11):
pubmed: 31752378
Liver Res. 2019 Mar;3(1):3-18
pubmed: 32461811
Gastroenterology. 2011 Oct;141(4):1249-53
pubmed: 21726509
Nature. 2008 Aug 7;454(7205):690-1
pubmed: 18685678
Liver Int. 2017 Sep;37(9):1389-1396
pubmed: 28235154
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3
pubmed: 29908364
Clin Pharmacokinet. 2000 May;38(5):415-26
pubmed: 10843460
Am J Gastroenterol. 2001 Mar;96(3):842-5
pubmed: 11280562
Int J Obes Relat Metab Disord. 2001 Mar;25(3):354-8
pubmed: 11319632
Liver Transpl. 2013 Aug;19(8):907-15
pubmed: 23744721
Transplant Proc. 2010 Mar;42(2):663-5
pubmed: 20304218
Transplantation. 2017 Aug;101(8):1867-1874
pubmed: 28296807
Hormones (Athens). 2018 Jun;17(2):219-229
pubmed: 29858843
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
J Biosci Bioeng. 2010 Dec;110(6):709-15
pubmed: 20691633
Transpl Int. 2005 Apr;18(4):461-6
pubmed: 15773968
Transplantation. 2018 Feb;102(2S Suppl 1):S44-S46
pubmed: 28230638
Gut. 2007 Mar;56(3):443-4
pubmed: 17339254
Gastroenterol Hepatol (N Y). 2016 Oct;12(10):601-608
pubmed: 27917074
World J Gastroenterol. 2014 Aug 21;20(31):10703-14
pubmed: 25152574
Liver Transpl. 2001 Apr;7(4):363-73
pubmed: 11303298
Gastroenterology. 2012 Oct;143(4):913-6.e7
pubmed: 22728514
BMC Gastroenterol. 2013 Sep 23;13:140
pubmed: 24053454
Clin Gastroenterol Hepatol. 2008 Apr;6(4):459-64
pubmed: 18387499
Cancer Epidemiol. 2011 Aug;35(4):309-19
pubmed: 21470937
Liver Transpl. 2013 May;19(5):551-62
pubmed: 23408499
Transplantation. 2000 Nov 27;70(10):1540-1
pubmed: 11118104
Diabetes. 2012 Feb;61(2):364-71
pubmed: 22190648
Ann Oncol. 2009 Feb;20(2):353-7
pubmed: 18723550
Transplantation. 2018 May;102(5):727-743
pubmed: 29485508
Transplantation. 2017 Dec;101(12):2873-2882
pubmed: 28817434
Lancet Oncol. 2009 Jul;10(7):653-62
pubmed: 19556163
Cochrane Database Syst Rev. 2018 Apr 09;4:CD007606
pubmed: 29630730
Diabetologia. 2012 Apr;55(4):885-904
pubmed: 22278337
Biomed Rep. 2018 Jul;9(1):90-96
pubmed: 29930810
Diabetol Metab Syndr. 2020 Jan 7;12:2
pubmed: 31921359
Am J Gastroenterol. 2010 Jan;105(1):178-87
pubmed: 19755965
Liver Transpl. 2007 Nov;13(11):1521-31
pubmed: 17969201
Diabetes Care. 2015 Jan;38(1):159-65
pubmed: 25538312
Nutr Res. 2020 Nov;83:1-14
pubmed: 32987284
Front Microbiol. 2018 Jul 20;9:1602
pubmed: 30079055
Aliment Pharmacol Ther. 2014 Apr;39(8):883-93
pubmed: 24612251
J Hepatol. 2016 Jun;64(6):1388-402
pubmed: 27062661
Clin Pharmacol Ther. 2017 Dec 22;:
pubmed: 29271075
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5
pubmed: 25865049
Transpl Int. 2013 Jan;26(1):67-74
pubmed: 23126674
Clin Transplant. 2012 Nov-Dec;26(6):910-8
pubmed: 22694047
Front Pharmacol. 2017 Jul 05;8:444
pubmed: 28725195
Sci Rep. 2018 Jun 27;8(1):9742
pubmed: 29950699
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Nature. 2006 Dec 21;444(7122):1022-3
pubmed: 17183309
Transplantation. 2001 Jul 15;72(1):156-9
pubmed: 11468551
Nutrients. 2019 Oct 23;11(11):
pubmed: 31652761
Transplantation. 1991 Apr;51(4):797-800
pubmed: 2014532
Transplant Rev (Orlando). 2018 Jan;32(1):69-77
pubmed: 28501338
Hepatogastroenterology. 2010 May-Jun;57(99-100):591-7
pubmed: 20698233
JAMA. 2007 Feb 28;297(8):842-57
pubmed: 17327526
Liver Transpl Surg. 1998 Jul;4(4):285-96
pubmed: 9649642
Transplantation. 2019 Nov;103(11):2287-2303
pubmed: 31283679
Int J Obes (Lond). 2015 Mar;39(3):438-46
pubmed: 25042861
Am J Clin Nutr. 2008 Feb;87(2):362-9
pubmed: 18258626
Clin Pharmacokinet. 2012 May 1;51(5):277-304
pubmed: 22448619
Aliment Pharmacol Ther. 2019 Oct;50(7):809-821
pubmed: 31475372
Sci Rep. 2017 Mar 28;7:45176
pubmed: 28349964
Hepatology. 2018 Mar;67(3):914-923
pubmed: 29023899
Liver Transpl. 2015 Jul;21(7):889-96
pubmed: 25880971
Liver Int. 2014 Apr;34(4):495-504
pubmed: 24102757
J Atheroscler Thromb. 2010 Oct 27;17(10):1019-32
pubmed: 20702976
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2365-70
pubmed: 19164560
Liver Transpl. 2007 Aug;13(8):1109-14
pubmed: 17663411
Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):412-25
pubmed: 27273168
Lipids Health Dis. 2021 Feb 26;20(1):22
pubmed: 33637088
Am J Cardiol. 1994 Mar 1;73(7):460-8
pubmed: 8141087
Am J Health Syst Pharm. 2006 Oct 1;63(19):1852-7
pubmed: 16990631
Ann Transl Med. 2017 Jul;5(13):270
pubmed: 28758096
Lancet. 2019 Nov 30;394(10213):2012-2024
pubmed: 31727409
Hepatol Int. 2020 Dec;14(6):930-943
pubmed: 33099753
Gastroenterology. 2015 Mar;148(3):547-55
pubmed: 25461851
Trends Endocrinol Metab. 2015 Sep;26(9):493-501
pubmed: 26257300
Diabetes. 1992 Jul;41(7):826-34
pubmed: 1612197
Liver Transpl. 2012 Oct;18(10):1209-16
pubmed: 22740290
BMJ. 2010 Nov 04;341:c5702
pubmed: 21051774
PLoS One. 2017 Oct 24;12(10):e0186990
pubmed: 29065187
Liver Transpl. 2011 Jan;17(1):15-22
pubmed: 21254340
Endocr Rev. 2007 Dec;28(7):763-77
pubmed: 17981890
Am J Clin Nutr. 2015 Nov;102(5):1070-80
pubmed: 26447154
Hepatol Int. 2013 Jun;7(2):741-8
pubmed: 26201809
Transplantation. 2019 Apr;103(4):668-678
pubmed: 30507741
Surg Endosc. 2013 Jan;27(1):81-5
pubmed: 22752278
Liver Transpl. 2008 Nov;14(11):1648-54
pubmed: 18975273
Liver Transpl. 2014 Sep;20(9):1064-71
pubmed: 24961607
Liver Transpl. 2010 Apr;16(4):431-9
pubmed: 20373454
Eur J Pharmacol. 2009 Jun 24;613(1-3):119-27
pubmed: 19358839
Br J Nutr. 2012 Feb;107(4):601-13
pubmed: 21767445
Clinics (Sao Paulo). 2009;64(3):235-44
pubmed: 19330251
Drug Saf. 2008;31(1):53-65
pubmed: 18095746
World J Gastroenterol. 2014 Sep 14;20(34):12330-40
pubmed: 25232269
Am J Gastroenterol. 2014 Jul;109(7):1065-71
pubmed: 24890442
Transplant Proc. 2005 Jul-Aug;37(6):2616-7
pubmed: 16182764
N Engl J Med. 2010 May 6;362(18):1675-85
pubmed: 20427778
Nature. 2009 Oct 29;461(7268):1282-6
pubmed: 19865172
Hepatology. 2004 Jan;39(1):188-96
pubmed: 14752837
Aliment Pharmacol Ther. 2017 Aug;46(3):236-245
pubmed: 28488418
Am J Gastroenterol. 2001 Feb;96(2):519-25
pubmed: 11232700
Clin Transplant. 2008 May-Jun;22(3):281-91
pubmed: 18482049
Sci Rep. 2019 Dec 31;9(1):20405
pubmed: 31892725
HPB (Oxford). 2015 Mar;17(3):251-7
pubmed: 25322849
Nutrients. 2020 Dec 23;13(1):
pubmed: 33374578
Sci Rep. 2017 Aug 31;7(1):10277
pubmed: 28860611
Metabolism. 1987 Jan;36(1):54-9
pubmed: 3796297
Transplantation. 2019 Jan;103(1):e14-e21
pubmed: 29994981
Obes Surg. 2013 Jul;23(7):1001-10
pubmed: 23595210
Prev Chronic Dis. 2017 Mar 16;14:E24
pubmed: 28301314
Sultan Qaboos Univ Med J. 2014 Feb;14(1):e95-e103
pubmed: 24516761
Liver Int. 2015 Jan;35(1):164-70
pubmed: 24313970
JACC Cardiovasc Imaging. 2014 Dec;7(12):1221-35
pubmed: 25440591
Clin Gastroenterol Hepatol. 2006 May;4(5):639-44
pubmed: 16630771
Int J Obes (Lond). 2012 Jun;36(6):817-25
pubmed: 21829158
World J Gastroenterol. 2012 Jul 28;18(28):3627-34
pubmed: 22851856
Diabetes. 1985 Oct;34(10):1055-8
pubmed: 4043554
Endocr Rev. 2000 Dec;21(6):697-738
pubmed: 11133069
Hepatology. 2010 Jan;51(1):121-9
pubmed: 19827166
Expert Opin Drug Saf. 2010 Mar;9(2):347-54
pubmed: 20175701
Surgery. 1989 Oct;106(4):750-6; discussion 756-7
pubmed: 2799651
Hepatology. 2002 Jan;35(1):105-9
pubmed: 11786965
Liver Transpl. 2009 Nov;15(11):1542-52
pubmed: 19877219
Ann Surg. 2005 Oct;242(4):610-7; discussion 618-20
pubmed: 16192822
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Int J Obes (Lond). 2008 Nov;32(11):1720-4
pubmed: 18779823
Br J Nutr. 1989 Mar;61(2):139-48
pubmed: 2706220
Physiol Behav. 2011 Nov 30;105(1):77-81
pubmed: 21315751
Curr Oncol Rep. 2011 Feb;13(1):71-6
pubmed: 21080117
Pharmacotherapy. 2018 Jul;38(7):758-768
pubmed: 29804307
Eur J Clin Microbiol Infect Dis. 2008 Aug;27(8):631-4
pubmed: 18322715
Front Microbiol. 2019 Jul 03;10:1518
pubmed: 31333622
Diabetes Care. 2010 Jan;33(1):184-9
pubmed: 19837793
Oncotarget. 2016 Apr 12;7(15):19355-66
pubmed: 27036035
Transplant Proc. 2005 May;37(4):1695-6
pubmed: 15919434
Nature. 2011 Apr 7;472(7341):57-63
pubmed: 21475195
Obes Res. 2004 Dec;12(12):1930-5
pubmed: 15687393
Br J Nutr. 2014 Apr 14;111(7):1147-61
pubmed: 24230488
Nat Rev Microbiol. 2009 Sep;7(9):616
pubmed: 21548178
Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):275-285
pubmed: 29431542
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1401-4
pubmed: 6426576
Transplant Proc. 2012 Sep;44(7):2005-6
pubmed: 22974893
Sci Rep. 2015 Dec 22;5:18559
pubmed: 26692421
Liver Transpl. 2009 Aug;15(8):968-77
pubmed: 19642131
Obes Surg. 2018 Feb;28(2):444-450
pubmed: 28766265
Liver Transpl. 2013 Oct;19(10):1125-31
pubmed: 23894084
JAMA. 2011 Oct 12;306(14):1549-56
pubmed: 21990298
JAMA. 1999 Jan 20;281(3):235-42
pubmed: 9918478
Hepatology. 2009 Jan;49(1):80-6
pubmed: 19053049
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Circulation. 2005 Oct 25;112(17):2735-52
pubmed: 16157765
Gastroenterology. 2008 Oct;135(4):1176-84
pubmed: 18718471
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
Immun Inflamm Dis. 2022 Jan;10(1):3-21
pubmed: 34598315
Am J Transplant. 2010 Jun;10(6):1420-7
pubmed: 20486907
Br J Pharmacol. 2017 Jul;174(13):1908-1924
pubmed: 28299773
Clin Transplant. 2017 Jun;31(6):
pubmed: 28342282
Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):40-50
pubmed: 22251469
Obes Surg. 2015 Jan;25(1):134-42
pubmed: 25337867
Nutr Hosp. 2012 Jul-Aug;27(4):1351-6
pubmed: 23165585
J Antimicrob Chemother. 2014 Mar;69(3):715-23
pubmed: 24214905
Liver Transpl. 2008 Sep;14(9):1287-93
pubmed: 18756451
Transplantation. 2010 Dec 27;90(12):1562-6
pubmed: 21048536
Medicine (Baltimore). 2012 Nov;91(6):319-327
pubmed: 23117851
Diabetes. 1989 Mar;38(3):304-9
pubmed: 2645187
Drug Metab Dispos. 2009 Oct;37(10):2087-94
pubmed: 19651758
Lancet. 2009 Mar 28;373(9669):1083-96
pubmed: 19299006
Horm Mol Biol Clin Investig. 2014 Jul;19(1):57-74
pubmed: 25390016
Am J Clin Nutr. 2011 Jul;94(1):58-65
pubmed: 21543530
PLoS One. 2015 Jul 10;10(7):e0126976
pubmed: 26161548
Ann Pharmacother. 2020 Feb;54(2):171-177
pubmed: 31441337
J Clin Transl Hepatol. 2018 Sep 28;6(3):264-275
pubmed: 30271738
J Physiol Pharmacol. 2003 Sep;54(3):319-27
pubmed: 14566071
Transplantation. 2019 Jan;103(1):57-67
pubmed: 30335694
Liver Transpl. 2008 Apr;14(4):512-25
pubmed: 18383081
Hepatology. 2016 Mar;63(3):764-75
pubmed: 26600078
Liver Int. 2014 Aug;34(7):1094-101
pubmed: 24517561

Auteurs

Kinga Czarnecka (K)

Department of Transplant Medicine, Nephrology and Internal Diseases, Medical University of Warsa, Warsaw, Poland.

Paulina Czarnecka (P)

Department of Transplant Medicine, Nephrology and Internal Diseases, Medical University of Warsa, Warsaw, Poland.

Olga Tronina (O)

Department of Transplant Medicine, Nephrology and Internal Diseases, Medical University of Warsa, Warsaw, Poland.

Teresa Bączkowska (T)

Department of Transplant Medicine, Nephrology and Internal Diseases, Medical University of Warsa, Warsaw, Poland.

Magdalena Durlik (M)

Department of Transplant Medicine, Nephrology and Internal Diseases, Medical University of Warsa, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH